AXGN · Company research
Axogen, Inc. Common Stock (AXGN): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 36.31 | $2,314,390,404.62 | 2219818404.62 | — | — | — | 33.1902655149072866 | 9.0315207179511194 | 365.73805382743362833352 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.